Regular screening, adhering to nutritional guidelines, and avoiding risky behaviors are the effective ways to keep kidneys ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

The move aims to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy to treat ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a ...

What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...

Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that ...